Solural Pharma has entered an agreement with Contera Pharma A/S to transfer all proprietary rights for the SOL 707 Morning Akinesia to Contera Pharma.
Recent news
- New patent acquisition agreement November 16, 2022
- New Eurasia patent December 25, 2020
- New Manufacturing Authorisation December 18, 2020
Career
If you are interested in joining Solural Pharma ApS, we are seeking professionals, technicians and consultants with expertise within drug development. Please contact
career@soluralpharma.com for more information about available positions.